Direct use of eazyplex^® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections

References

• Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13(47):e19044.
   PubMedGoogle Scholar
• Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51(6):1987–1994. doi:10.1128/AAC.01509-0617387156
   PubMed Web of Science ®Google Scholar
• Rossolini GM, D‘Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactams. Clin Microbiol Infect. 2008;14(Suppl 1):33–41. doi:10.1111/j.1469-0691.2007.01863.x18154526
   PubMed Web of Science ®Google Scholar
• Castanheira M, Mendes RE, Jones RN, Sader HS. Changes in the frequencies of β-lactamase genes among Enterobacteriaceae isolates in U.S. hospitals, 2012 to 2014: activity of ceftazidime-avibactam tested against β-lactamase-producing isolates. Antimicrob Agents Chemother. 2016;60(8):4770–4777. doi:10.1128/AAC.00540-1627216075
   PubMed Web of Science ®Google Scholar
• Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873–5884. doi:10.1128/AAC.01019-1526169401
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Chen L, Patel G, et al. Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States. Antimicrob Agents Chemother. 2017;61:e02349–16. doi:10.1128/AAC.02349-1628167547
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing Kp: importance of combination therapy. Clin Infect Dis. 2012;55(7):943–950. doi:10.1093/cid/cis58822752516
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M, Trecarichi EM, et al. Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerg Infect Dis. 2014;20(7):1235–1236. doi:10.3201/eid2007.13009424960464
   PubMed Web of Science ®Google Scholar
• La Scola B, Raoult D, Bereswill S. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One. 2009;4:e8041. doi:10.1371/journal.pone.000804119946369
   PubMed Web of Science ®Google Scholar
• Fiori B, D’Inzeo T, Giaquinto A, et al. Optimized use of the MALDI BioTyper system and the Filmarray BCID panel for direct identification of microbial pathogens from positive blood cultures. J Clin Microbiol. 2016;54(3):576–584.26677254
   PubMed Web of Science ®Google Scholar
• Bork JT, Leekha S, Heil EL, Zhao L, Badamas R, Johnson JK. Rapid testing using the verigene gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against gram-negative bacteremia. Antimicrob Agents Chemother. 2015;59(3):1588–1595. doi:10.1128/AAC.04259-14 25547353
   PubMed Web of Science ®Google Scholar
• Sothoron C, Ferreira J, Guzman N, et al. A stewardship approach to optimize antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for gram-negative bacteria. J Clin Microbiol. 2015;53(11):3627–3629. doi:10.1128/JCM.02161-15 26292308
   PubMed Web of Science ®Google Scholar
• Buehler SS, Madison B, Snyder SR, et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev. 2016;29(1):59–103. doi:10.1128/CMR.00053-1426598385
   PubMed Web of Science ®Google Scholar
• Bookstaver PB, Nimmich EB, Smith TJ 3rd, et al. Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections. Antimicrob Agents Chemother. 2017;61:e00189–17. doi:10.1128/AAC.00189-1728630187
   PubMed Web of Science ®Google Scholar
• MacVane SH, Nolte FS, Burnham C-AD. Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol. 2016;54:2455–2463. doi:10.1128/JCM.00996-1627487951
   PubMed Web of Science ®Google Scholar
• Findlay J, Hopkins KL, Meunier D, Woodford N. Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria. J Antimicrob Chemother. 2015;70(5):1338–1342. doi:10.1093/jac/dku44525630646
   PubMed Web of Science ®Google Scholar
• García-Fernández S, Morosini MI, Marco F, et al. Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals. J Antimicrob Chemother. 2015;70(4):1047–1050. doi:10.1093/jac/dku44525428926
   PubMed Web of Science ®Google Scholar
• Hinić V, Ziegler J, Straub C, Goldenberger D, Frei R. Extended-spectrum β-lactamase (ESBL) detection directly from urine samples with the rapid isothermal amplification-based eazyplex® SuperBug CRE assay: proof of concept. J Microbiol Methods. 2015;119:203–205. doi:10.1016/j.mimet.2015.10.01526506282
   PubMed Web of Science ®Google Scholar
• Fantoni M, Murri R, Scoppettuolo G, et al. Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? Future Microbiol. 2015;10(1):15–20. doi:10.2217/fmb.14.9925598334
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother. 2006;50(2):498–504. doi:10.1128/AAC.50.2.498-504.200616436702
   PubMed Web of Science ®Google Scholar
• Pagani L, Dell‘Amico E, Migliavacca R, et al. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol. 2003;41(9):4264–4269. doi:10.1128/JCM.41.9.4264-4269.200312958255
   PubMed Web of Science ®Google Scholar
• Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC -lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–2162. doi:10.1128/JCM.40.6.2153-2162.200212037080
   PubMed Web of Science ®Google Scholar
• Banerjee R, Teng CB, Cunningham SA, et al. Randomized trial of rapid multiplex polymerase chain reaction–based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61(7):1071–1080. doi:10.1093/cid/civ44726197846
   PubMed Web of Science ®Google Scholar
• Walker T, Dumadag S, Lee CJ, et al. Clinical impact after laboratory implementation of the verigene gram-negative bacteria microarray for positive blood cultures. J Clin Microbiol. 2016;54(7):1789–1796. doi:10.1128/JCM.00376-1627098961
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Sali M, Trecarichi EM, et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother. 2008;52(9):3244–3252. doi:10.1128/AAC.00063-0818591273
   PubMed Web of Science ®Google Scholar
• Capone A, Giannella M, Fortini D, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19(1):23–30. doi:10.1111/1469-0691.1207023034105
   PubMed Web of Science ®Google Scholar
• Monaco M, Giani T, Raffone M, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, november 2013 to april 2014. Euro Surveill. 2014;19:e20939. doi:10.2807/1560-7917.ES2014.19.42.20939
   PubMedGoogle Scholar
• Giani T, Antonelli A, Caltagirone M, et al. Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients. Euro Surveill. 2017;22:e30583. doi:10.2807/1560-7917.ES.2017.22.31.30583
   PubMedGoogle Scholar
• Gutiérrez-Gutiérrez B, Pérez-Galera S, Salamanca E, et al. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2016;60(7):4159–4169. doi:10.1128/AAC.00365-1627139473
   PubMed Web of Science ®Google Scholar
• Ng TM, Khong WX, Harris PN, et al. Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. PLoS One. 2016;11:e0153696. doi:10.1371/journal.pone.015369627104951
   PubMed Web of Science ®Google Scholar
• Tamma PD, Han JH, Rock C, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Clin Infect Dis. 2015;60(9):1319–1325.25586681
   PubMed Web of Science ®Google Scholar
• Ofer-Friedman H, Shefler C, Sharma S, et al. Carbapenems versus piperacillin-tazobactam for bloodstream infections of nonurinary source caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol. 2015;36(8):981–985. doi:10.1017/ice.2015.10125990361
   PubMed Web of Science ®Google Scholar
• Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with Escherichia coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984–994. doi:10.1001/jama.2018.1216330208454
   PubMed Web of Science ®Google Scholar